Home /
Case study

A two-month lockdown in Shanghai

When Shanghai went into lockdown to prevent the spread of the Omicron COVID-19 variant, our client’s important work in clinical trials had to continue.
To minimize the impact of this unprecedented situation, Almac Clinical Technologies worked closely with our sponsors to develop low-risk, multifaceted solutions to handle each client’s unique set of needs and challenges.

Read how in our new case study.

View Resource
Almac Logo

Almac Clinical Technologies

Almac Clinical Technologies is here to help the biopharmaceutical industry bring new therapies to those in need by empowering clinical trial sponsors to proactively manage sites, patients, and clinical trial supplies through our industry-leading Interactive Response Technology (IRT) and expert consultancy.

Almac Clinical Technologies is uniquely positioned to unlock new efficiencies in the clinical supply chain and to help achieve greater predictability in your projects and programs.

Our professionals are dedicated to delivering high-quality Interactive Response Technology (IRT) solutions, dependable professional services, and reliable customer service. Our expertise, energy, and commitment have earned us a reputation as a trusted ally in the drug development process.

Learn More

Download here instantly

This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies